Listed by the USPTO as FARRAR, LAUREN PENG
Tech Center 3900 • Art Units: 3763 3767 3783 3902
This examiner grants 79% of resolved cases
FARRAR, LAUREN PENG is a USPTO patent examiner in Tech Center 3900 and Art Unit 3763. The profile includes 793 resolved cases, a 78.7% allowance rate, and a 15.6% interview lift. Median time to allowance is 2199 days, making timing a significant planning consideration.
Sanofi S.A., Terumo Corporation, and Becton, Dickinson and Company are the leading companies represented. Knobbe, Martens, Olson & Bear, LLP, BUCHANAN INGERSOLL & ROONEY PC, and BakerHostetler - Inovio are the leading firms. The allowance figure indicates favorable recorded outcomes, but the median timing figure calls for early attention to response schedules, continuation decisions, and portfolio coordination.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18202702 | Catheter Placement Device Including a Mechanical Advantage Mechanism | Non-Final OA | Bard Access Systems, Inc. |
| 18446204 | SUCTION VALVE FOR AN ENDOSCOPE | Non-Final OA | Boston Scientific Scimed, Inc. |
| 17782313 | FIXED DOSE INJECTION DEVICE | Non-Final OA | Novo Nordisk A/S |
| 18348645 | TREATMENT DEVICE OF CEREBROVASCULAR DISORDER | Final Rejection | TERUMO KABUSHIKI KAISHA |
| 18097980 | PRE-FILLED SYRINGE | Non-Final OA | TERUMO KABUSHIKI KAISHA |
| 18737211 | NEEDLELESS ACCESS CONNECTOR WITH ANTIMICROBIAL RESISTANT VALVE | Non-Final OA | CareFusion 303, Inc. |
| 17795284 | BLOOD PUMP PLACEMENT AND INTRAVASCULAR BLOOD PUMP | Final Rejection | Abiomed Europe GmbH |
| 18750170 | Automated System for Assembling A Pre-Filled Syringe | Non-Final OA | W. L. Gore & Associates, Inc. |
| 17441021 | INJECTOR ACCESSORIES | Non-Final OA | AMGEN INC. |
| 18447258 | INFLATABLE MEDICAL BALLOONS | Final Rejection | Becton, Dickinson and Company |
| 18204589 | Rigid Needle Shield Remover with Connection Confirmation Feature for Autoinjector | Final Rejection | Becton, Dickinson and Company |
| 17758539 | Biodegradable and Multifunctional Neural Block Devices | Final Rejection | The Penn State Research Foundation |
| 18673616 | ADHESIVE AND PERIPHERAL SYSTEMS AND METHODS FOR MEDICAL DEVICES | Non-Final OA | DEKA Products Limited Partnership |
| 18019500 | DRUG DELIVERY DEVICE AND MODULE HEREWITH | Final Rejection | Sanofi |
| 17918236 | Drug Delivery Device | Final Rejection | Sanofi |
| 17886279 | PEN-TYPE DRUG INJECTION DEVICE WITH CONTROLLER AND TIME LOCK-OUT MECHANISM FOR ITS DRIVE | Final Rejection | Sanofi-Aventis Deutschland GmbH |
| 18287046 | SYSTEMS FOR OUT-PATIENT TREATMENT OF A PATIENT, AND RELATED METHODS | Non-Final OA | AMGEN RESEARCH MUNICH GMBH |
| 18126347 | METHODS, SYSTEMS AND DEVICES FOR ADMINISTERING MEDICATION | Final Rejection | Individual inventor |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy78.7% of resolved applications examined by Lauren Peng Farrar were allowed (793 resolved cases), compared with 60.3% across Art Unit 3763 over the last five years.
This examiner's interview lift is +15.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Lauren Peng Farrar took 2,199 days on average from filing to allowance.
Lauren Peng Farrar examines applications in Art Unit 3763 in Tech Center 3900.
